Plasma Thromboplastin Antecedent

from Wikipedia, the free encyclopedia
Plasma Thromboplastin Antecedent
Plasma Thromboplastin Antecedent
Belt / surface model according to PDB  2F83

Existing structural data : see UniProt P03951

Properties of human protein
Mass / length primary structure 607 amino acids
Secondary to quaternary structure Homodimer
Isoforms 2
Identifier
Gene names F11  ; FXI; MGC141891
External IDs
Enzyme classification
EC, category 3.4.21.27 serine protease
MEROPS S01.213
Response type Proteolysis
Substrate Arg - + - Ala or Arg - + - Val in factor IX
Products Factor IXa
Occurrence
Homology family Kallikrein
Parent taxon Terrestrial vertebrates
Orthologue
human House mouse
Entrez 2160 109821
Ensemble ENSG00000088926 ENSMUSG00000031645
UniProt P03951 Q91Y47
Refseq (mRNA) NM_000128 NM_028066
Refseq (protein) NP_000119 NP_082342
Gene locus Chr 4: 186.27 - 186.29 Mb Chr 8: 45.24 - 45.26 Mb
PubMed search 2160 109821

Plasma Thromboplastin Antecedent ( factor XI or PTA for short, English for the predecessor of plasma thromboplastin ), also Rosenthal factor, is an enzyme involved in blood clotting , more precisely a serine proteinase . It is produced by the liver and circulates as a homo-dimer ( covalently linked to one another via a disulfide bridge ) in its inactive form. The monomer has a molecular weight of 80  kDa . The concentration in plasma is 5 mg / l, its half-life is about 52 hours.

genetics

In humans, the gene for factor XI is on chromosome 4 , gene locus q32-35. It is 23 kbp in length and consists of 15 exons .

physiology

PTA is activated by activated Hageman factor (factor XIIa) or by thrombin and is then referred to as factor XIa. It belongs to the intrinsic pathway of blood clotting, which comes into action when Hageman factor and other components encounter negatively charged collagen under the endothelium of the vessel wall .

Factor XIa activates the Christmas factor (factor IX) by cleavage of an Arg - Ala - and Arg - Val - peptide binding to Factor IXa. The (activated) Christmas factor then activates the Stuart-Prower factor (factor X).

Diseases

Lack of PTA causes the rare hemophilia C . This occurs more frequently (8%) among Ashkenazi Jews , while in other populations it only affects about 1% of the population. In this type of haemophilia, spontaneous bleeding is rare, but surgery can cause severe blood loss and requires special preparation.

Low PTA levels can also occur in other diseases, such as Noonan's syndrome .

Elevated PTA levels are believed to play a role in causing thrombosis , but it is uncertain which factors cause the elevated levels and how severe the coagulant effects are.

Web links

Individual evidence

  1. R. Asakai, DW Chung, EW Davie, U. Seligsohn: Factor XI deficiency in Ashkenazi Jews in Israel. In: The New England Journal of Medicine . Volume 325, Number 3, July 1991, pp. 153-158, doi : 10.1056 / NEJM199107183250303 , PMID 2052060 .
  2. RM Bertina: Elevated clotting factor levels and venous thrombosis. In: Pathophysiology of haemostasis and thrombosis. Volume 33, Number 5-6, 2003 Sep-2004 Dec, pp 395-400, doi : 10.1159 / 000083835 , PMID 15692250 (review).
  3. ^ A. Siegemund, S. Petros, T. Siegemund, U. Scholz, HJ Seyfarth, L. Engelmann: The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XI. In: Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis. Volume 15, Number 3, April 2004, pp. 241-244, PMID 15060420 .